Evidence map›Paper›PMID 32708646›Full record

ArticleNanomaterials (Basel, Switzerland)2020

Argovit™ Silver Nanoparticles Effects on

Francisco Casillas-Figueroa, María Evarista Arellano-García, Claudia Leyva-Aguilera, Balam Ruíz-Ruíz, Roberto Luna Vázquez-Gómez, Patricia Radilla-Chávez, Rocío Alejandra Chávez-Santoscoy, Alexey Pestryakov, Yanis Toledano-Magaña, Juan Carlos García-Ramos and 1 more

Open access · goldAbstract read
In one paragraph

Article in Nanomaterials (Basel, Switzerland), 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 50 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Review
  11. Treatment with ArgovitNanomaterials (Basel, Switzerland) · 2021
    Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 2 countries.

Francisco Casillas-FigueroaEscuela de Ciencias de la Salud, UABC, Blvd. Zertuche y Blvd., De los Lagos S/N Fracc, Valle Dorado, 22890 Ensenada, Baja California, Mexico.
María Evarista Arellano-GarcíaFacultad de Ciencias, UABC, Carretera Transpeninsular Ensenada-Tijuana No. 3917 Col. Playitas, 22860 Ensenada, Baja California, Mexico.ORCID 0000-0002-0997-6902
Claudia Leyva-AguileraFacultad de Ciencias, UABC, Carretera Transpeninsular Ensenada-Tijuana No. 3917 Col. Playitas, 22860 Ensenada, Baja California, Mexico.
Balam Ruíz-RuízFacultad de Medicina extensión los Mochis, Universidad Autónoma de Sinaloa, Av. Ángel Flores s/n, Ciudad Universitaria, 81223 Los Mochis, Sinaloa, Mexico.ORCID 0000-0003-2292-5891
Roberto Luna Vázquez-GómezEscuela de Ciencias de la Salud, UABC, Blvd. Zertuche y Blvd., De los Lagos S/N Fracc, Valle Dorado, 22890 Ensenada, Baja California, Mexico.
Patricia Radilla-ChávezEscuela de Ciencias de la Salud, UABC, Blvd. Zertuche y Blvd., De los Lagos S/N Fracc, Valle Dorado, 22890 Ensenada, Baja California, Mexico.
Rocío Alejandra Chávez-SantoscoyCentro de Biotecnología-FEMSA, Escuela de Ingeniería y Ciencias, ITESM, Monterrey, Eugenio Garza Sada, 2501 Sur, 64849 Monterrey, Nuevo León, Mexico.ORCID 0000-0002-4551-1862
Alexey PestryakovDepartment of Technology of Organic Substances and Polymer Materials, Tomsk Polytechnic University, 634050 Tomsk, Russia.
Yanis Toledano-MagañaEscuela de Ciencias de la Salud, UABC, Blvd. Zertuche y Blvd., De los Lagos S/N Fracc, Valle Dorado, 22890 Ensenada, Baja California, Mexico.ORCID 0000-0002-2595-7939
Juan Carlos García-RamosEscuela de Ciencias de la Salud, UABC, Blvd. Zertuche y Blvd., De los Lagos S/N Fracc, Valle Dorado, 22890 Ensenada, Baja California, Mexico.ORCID 0000-0001-9861-2467
Nina BogdanchikovaCentro de Nanociencias y Nanotecnología, UNAM, Carretera Tijuana-Ensenada Km 107, 22860 Ensenada, Baja California, Mexico.
National Research Tomsk State University · RUTecnológico de Monterrey · MXUniversidad Autónoma de Sinaloa · MX

Funding

Consejo Nacional de Ciencia y Tecnología 293417Tomsk Polytechnic University VIU-ISHBMT-65/2019
6 · The paper itself

Abstract

Due to their antibacterial and antiviral effects, silver nanoparticles (AgNP) are one of the most widely used nanomaterials worldwide in various industries, e.g., in textiles, cosmetics and biomedical-related products. Unfortunately, the lack of complete physicochemical characterization and the variety of models used to evaluate its cytotoxic/genotoxic effect make comparison and decision-making regarding their safe use difficult. In this work, we present a systematic study of the cytotoxic and genotoxic activity of the commercially available AgNPs formulation Argovit™ in

Indexed as

Allium cepaantioxidant activitycytotoxicgenotoxicmetal/coating agent rationongenotoxic silver nanoparticlessilver ions

Identifiers

PMID32708646
PMCPMC7408422
OpenAlexW3043415836

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.